Advertisement

Journal of Inherited Metabolic Disease

, Volume 15, Issue 5, pp 713–719 | Cite as

Prenatal diagnosis of Non-ketotic hyperglycinaemia

  • J. R. Toone
  • D. A. Applegarth
  • H. L. Levy
Article

Summary

Non-ketotic hyperglycinaemia (NKH) is a devastating neurological disease for which there is no effective therapy. Consequently, most couples with a pregnancy known to be at risk for NKH request prenatal diagnosis. We have applied the combination of chorionic villus (CVS) assay for glycine cleavage enzyme activity and determination of amniotic fluid glycine concentration to increase the reliability of prenatal diagnosis for this disorder beyond that of each of these methods alone. All 15 of the at-risk pregnancies monitored had CVS glycine cleavage assay and five also had amniotic fluid glycine measurements. Two cases had no detectable cleavage activity in CVS and one gave uninterpretable enzyme results. Amniotic fluid glycine concentration was increased in all three and NKH was confirmed by abortus tissue assays for cleavage activity and amino acids. The remaining 12 case had activity in CVS (two also had normal amniotic fluid glycine levels) and delivered unaffected infants. Four of these 12 cases had cleavage activities below or at the low end of the normal range, perhaps indicating carrier status. We believe that the combination of CVS glycine cleavage assay and amniotic fluid glycine measurement is currently the best approach to the prenatal diagnosis of NKH.

Keywords

Glycine Neurological Disease Effective Therapy Prenatal Diagnosis Carrier Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Applegarth DA, Levy HL, Shih VE et al (1986) Prenatal diagnosis of non-ketotic hyperglycinemia.Prenat Diagn 6: 257–263Google Scholar
  2. Bruin WJ, May Frantz B, Sallach HJ (1973) The occurrence of a glycine cleavage system in mammalian brain.J Neurochem 20: 1649–1658Google Scholar
  3. Garcia-Castro JM, Isales-Forsythe CM, Levy HL et al (1982) Prenatal diagnosis of non-ketotic hyperglycinemia.N Engl J Med 306: 79–81Google Scholar
  4. Garcia-Munoz MJ, Belloque J, Menineno B, Periz-Cerda C, Sanz P, Ugarte M (1989) Non-ketotic hyperglycinaemia: Glycine/serine ratio in amniotic fluid — An unreliable method for prenatal diagnosis.Prenat Diagn 9: 473–476Google Scholar
  5. Hayasaka K, Tada K, Fueki N et al (1987) Feasibility of prenatal diagnosis of non-ketotic hyperglycinemia: existence of the glycine cleavage system in placenta.J Pediatr 110: 124–126Google Scholar
  6. Hayasaka K, Tada K, Fueki N, Aikawa J (1990) Prenatal diagnosis of non-ketotic hyperglycinemia: Enzymatic analysis of the glycine cleavage system in chorionic villi.J Pediatr 116: 444–445Google Scholar
  7. Koyata H, Hiraga K (1991) The glycine cleavage system: Structures of a cDNA encoding human H-protein, and a partial characterization of its gene in patients with hyperglycinemias.Am J Hum Genet 48: 351–361Google Scholar
  8. Kume A, Koyata H, Sakakibara T, Ishiguro Y, Kure S, Hiraga K (1991) Molecular cloning of the chicken and human glycine decarboxylase cDNAs and some characteristics involved in the deduced protein structures.J Biol Chem 266: 3323–3329Google Scholar
  9. Mesavage C, Nance CS, Flannery DB, Weiner DL, Suchy SF, Wolf B (1983) Glycine/serine ratios in amniotic fluid: an unreliable indicator for the prenatal diagnosis of non-ketotic hyperglycinemia.Clin Genet 23: 354–358Google Scholar
  10. Nachlas MM, Marqulies SI, Seligman AM (1960) A colourimetric method for the estimation of succinate dehydrogenase activity.J Biol Chem 235: 499–503Google Scholar
  11. Parvy P, Rabier D, Boue J, Saudubray JM, Kamoun P (1990) Glycine/serine ratio and the prenatal diagnosis of non-ketotic hyperglycinaemia.Prenat Diagn 10: 303–305Google Scholar
  12. Tada K, Aikawa J, Igarashi Y et al (1989) A survey on prenatal diagnosis of inherited metabolic disease in Japan.J Inher Metab Dis 12 (suppl 2): 260–262Google Scholar
  13. Toone JR, Applegarth DA (1989) Use of placental enzyme analysis in assessment of the newborn at risk for non-ketotic hyperglycinemia (NKH).J Inher Metab Dis 12: 281–285Google Scholar
  14. von Wendt L, Simila S, Ruokonen A, Hartikainen-Sorri AL (1983) Problems of prenatal diagnosis of non-ketotic hyperglycinemia.J Inher Metab Dis 6: 112–113Google Scholar

Copyright information

© SSIEM and Kluwer Academic Publishers 1992

Authors and Affiliations

  • J. R. Toone
    • 1
  • D. A. Applegarth
    • 1
  • H. L. Levy
    • 2
    • 3
  1. 1.Department of Pathology, Biochemical Diseases LaboratoryBC Children's HospitalVancouverCanada
  2. 2.Joseph P. Kennedy, Jr Laboratories of the Neurology ServiceMassachusetts General HospitalUSA
  3. 3.Department of NeurologyHarvard Medical SchoolBostonUSA

Personalised recommendations